Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

No Added Value of 18F-Sodium Fluoride PET/CT for the Detection of Bone Metastases in Patients with Newly Diagnosed Prostate Cancer with Normal Bone Scintigraphy

Helle D. Zacho, Mads R. Jochumsen, Niels C. Langkilde, Jesper C. Mortensen, Christian Haarmark, Helle W. Hendel, Jørgen B. Jensen and Lars J. Petersen
Journal of Nuclear Medicine December 2019, 60 (12) 1713-1716; DOI: https://doi.org/10.2967/jnumed.119.229062
Helle D. Zacho
1Department of Nuclear Medicine, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
2Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mads R. Jochumsen
3Department of Urology, Regional Hospital West Jutland, Herning, Denmark
4Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Aarhus, Denmark
5Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niels C. Langkilde
6Department of Urology, Aalborg University Hospital, Aalborg, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesper C. Mortensen
7Department of Nuclear Medicine, Regional Hospital West Jutland, Herning, Denmark; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Haarmark
8Department. of Clinical Physiology and Nuclear Medicine, Herlev and Gentofte Hospital, Herlev, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helle W. Hendel
8Department. of Clinical Physiology and Nuclear Medicine, Herlev and Gentofte Hospital, Herlev, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jørgen B. Jensen
3Department of Urology, Regional Hospital West Jutland, Herning, Denmark
5Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars J. Petersen
1Department of Nuclear Medicine, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
2Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 60 no. 12 1713-1716
DOI 
https://doi.org/10.2967/jnumed.119.229062
PubMed 
31147402

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication March 22, 2019
  • Accepted for publication May 23, 2019
  • Published online December 2, 2019.

Article Versions

  • previous version (May 30, 2019 - 14:34).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Helle D. Zacho1,2,
  2. Mads R. Jochumsen3–5,
  3. Niels C. Langkilde6,
  4. Jesper C. Mortensen7,
  5. Christian Haarmark8,
  6. Helle W. Hendel8,
  7. Jørgen B. Jensen3,5 and
  8. Lars J. Petersen1,2
  1. 1Department of Nuclear Medicine, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
  2. 2Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
  3. 3Department of Urology, Regional Hospital West Jutland, Herning, Denmark
  4. 4Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Aarhus, Denmark
  5. 5Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  6. 6Department of Urology, Aalborg University Hospital, Aalborg, Denmark
  7. 7Department of Nuclear Medicine, Regional Hospital West Jutland, Herning, Denmark; and
  8. 8Department. of Clinical Physiology and Nuclear Medicine, Herlev and Gentofte Hospital, Herlev, Denmark
  1. For correspondence or reprints contact: Helle Damgaard Zacho, Aalborg, of Nuclear Medicine, Aalborg University Hospital, Hobrovej 18-22, Postboks 365, DK-9100 Aalborg, Denmark. E-mail: h.zacho{at}rn.dk
View Full Text

Statistics from Altmetric.com

Cited By...

  • 11 Citations
  • 14 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • A critical assessment of technical advances in pharmaceutical removal from wastewater – A critical review
    Vinay Kumar, Sivarama Krishna Lakkaboyana, Neha Sharma, Pritha Chakraborty, Mridul Umesh, Ritu Pasrija, Jithin Thomas, Vishal U. Kalebar, Iyyappan Jayaraj, Mukesh Kumar Awasthi, Theerthankar Das, Akeem Adeyemi Oladipo, Damia Barcelo, Ludovic F. Dumee
    Case Studies in Chemical and Environmental Engineering 2023 8
  • Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy
    Helle D. Zacho, Søren Ravn, Ali Afshar-Oromieh, Joan Fledelius, June A. Ejlersen, Lars J. Petersen
    EJNMMI Research 2020 10 1
  • 18F-Sodium Fluoride PET: History, Technical Feasibility, Mechanism of Action, Normal Biodistribution, and Diagnostic Performance in Bone Metastasis Detection Compared with Other Imaging Modalities
    Kriti Ahuja, Houman Sotoudeh, Samuel J. Galgano, Ramandeep Singh, Nishant Gupta, Siddhartha Gaddamanugu, Gagandeep Choudhary
    Journal of Nuclear Medicine Technology 2020 48 1
  • Head-To-Head Comparison of 68Ga-PSMA-11 PET/CT and 99mTc-MDP Bone Scintigraphy for the Detection of Bone Metastases in Patients With Prostate Cancer: A Meta-Analysis
    Gege Zhao, Bin Ji
    American Journal of Roentgenology 2022 219 3
  • Observer Agreement and Accuracy of 18F-Sodium Fluoride PET/CT in the Diagnosis of Bone Metastases in Prostate Cancer
    Helle D. Zacho, Randi F. Fonager, Julie B. Nielsen, Christian Haarmark, Helle W. Hendel, Martin B. Johansen, Jesper C. Mortensen, Lars J. Petersen
    Journal of Nuclear Medicine 2020 61 3
  • Improved Diagnostic Accuracy of Bone Metastasis Detection by Water-HAP Associated to Non-Contrast CT
    Yoshinobu Ishiwata, Yojiro Hieda, Soichiro Kaki, Shinjiro Aso, Keiichi Horie, Yusuke Kobayashi, Motoki Nakamura, Kazuhiko Yamada, Tsuneo Yamashiro, Daisuke Utsunomiya
    Diagnostics 2020 10 10
  • Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers
    Wietske I. Luining, Dennie Meijer, Max R. Dahele, André N. Vis, Daniela E. Oprea-Lager
    Diagnostics 2021 11 1
  • Advances in high-risk localized prostate cancer: Staging and management
    Yeison Reina, Catalina Villaquirán, Herney Andrés García-Perdomo
    Current Problems in Cancer 2023 47 4
  • Reporting and handling of equivocal imaging findings in diagnostic studies of bone metastasis in prostate cancer
    Lars J Petersen, Martin N Johansen, Jesper Strandberg, Louise Stenholt, Helle D Zacho
    Acta Radiologica 2020 61 8
  • Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine?
    Eric Ouvrard, Ashjan Kaseb, Nathan Poterszman, Clémence Porot, Francois Somme, Alessio Imperiale
    Frontiers in Medicine 2024 10

Article usage

Article usage: May 2019 to April 2025

AbstractFullPdf
May 201912509
Jun 20197280113
Jul 201916409
Aug 201910807
Sep 20199905
Oct 2019111013
Nov 20198808
Dec 2019112616115
Jan 2020350934
Feb 2020212316
Mar 202015018
Apr 202088210
May 202010936
Jun 2020861749
Jul 2020561221
Aug 202046947
Sep 2020721728
Oct 2020411414
Nov 2020382021
Dec 2020497714
Jan 2021212121
Feb 2021201514
Mar 2021182216
Apr 2021182112
May 2021182716
Jun 2021162210
Jul 2021691720
Aug 20219219
Sep 2021142713
Oct 202193723
Nov 2021233644
Dec 202192812
Jan 2022123014
Feb 202212107
Mar 2022172019
Apr 20225116
May 202261920
Jun 20228812
Jul 20223149
Aug 20223149
Sep 202261414
Oct 202261819
Nov 2022152417
Dec 202241911
Jan 2023132811
Feb 20236103
Mar 202372111
Apr 2023151313
May 202310116
Jun 202371710
Jul 202361110
Aug 202381011
Sep 202371910
Oct 20231197
Nov 202384515
Dec 20237317
Jan 202422413
Feb 20249148
Mar 202442730
Apr 202462819
May 202433613
Jun 202464010
Jul 202442220
Aug 2024122523
Sep 202452811
Oct 202443020
Nov 20243215
Dec 20246227
Jan 202531415
Feb 20254437
Mar 202552914
Apr 202563121
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 60 (12)
Journal of Nuclear Medicine
Vol. 60, Issue 12
December 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
No Added Value of 18F-Sodium Fluoride PET/CT for the Detection of Bone Metastases in Patients with Newly Diagnosed Prostate Cancer with Normal Bone Scintigraphy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
No Added Value of 18F-Sodium Fluoride PET/CT for the Detection of Bone Metastases in Patients with Newly Diagnosed Prostate Cancer with Normal Bone Scintigraphy
Helle D. Zacho, Mads R. Jochumsen, Niels C. Langkilde, Jesper C. Mortensen, Christian Haarmark, Helle W. Hendel, Jørgen B. Jensen, Lars J. Petersen
Journal of Nuclear Medicine Dec 2019, 60 (12) 1713-1716; DOI: 10.2967/jnumed.119.229062

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
No Added Value of 18F-Sodium Fluoride PET/CT for the Detection of Bone Metastases in Patients with Newly Diagnosed Prostate Cancer with Normal Bone Scintigraphy
Helle D. Zacho, Mads R. Jochumsen, Niels C. Langkilde, Jesper C. Mortensen, Christian Haarmark, Helle W. Hendel, Jørgen B. Jensen, Lars J. Petersen
Journal of Nuclear Medicine Dec 2019, 60 (12) 1713-1716; DOI: 10.2967/jnumed.119.229062
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • KEY POINTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • 18F-Sodium Fluoride PET: History, Technical Feasibility, Mechanism of Action, Normal Biodistribution, and Diagnostic Performance in Bone Metastasis Detection Compared with Other Imaging Modalities
  • Google Scholar

More in this TOC Section

Oncology

  • The Evolving Role of FDG-PET/CT in Assessing Primary Cutaneous Lymphoma
  • Molecular imaging of Renal clear cell carcinoma subtypes as metabolic diseases
  • Role of PET/CT in the management of multiple myeloma
Show more Oncology

Clinical

  • Dual PET Imaging in Bronchial Neuroendocrine Neoplasms: The NETPET Score as a Prognostic Biomarker
  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Show more Clinical

Similar Articles

Keywords

  • 18F-sodium fluoride PET/CT
  • bone scintigraphy
  • prostate cancer
  • radical prostatectomy
SNMMI

© 2025 SNMMI

Powered by HighWire